Antimicrobial Surgical Suture Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

The antimicrobial surgical suture market size is projected to reach US$ 0.75 billion by 2031 from US$ 0.35 billion in 2023. The market is expected to register a CAGR of 9.9% in 2023–2031. Smart antimicrobial sutures are likely to act as key trends in the antimicrobial surgical suture market.

Antimicrobial Surgical Suture Market Analysis

Factors responsible for the market growth include the rising prevalence of surgical site infections and increasing cases of chronic wounds and surgeries. However, noninvasive alternatives to stitches limit the antimicrobial surgical suture market growth.

Antimicrobial Surgical Suture Market Overview

Sutures are frequently used to close postoperative wounds and to treat deep wounds caused during road and occupational accidents, orthopedic injuries, and sports injuries, owing to their ability to stimulate natural healing. Suturing has significantly transformed the wound closure process by accelerating it. However, wound care management is a complex process, and surgical site infections are the most common medical infections observed among the large population. As per the Centers for Disease Control And Prevention (CDC) 2024 report, surgical site infections account for 20% of all hospital-acquired infections, and they are associated with 2–11-fold increase in mortality in 75% of death cases related to surgical site complications. Additionally, surgical site infections contribute significantly to postoperative mortality and morbidity rates. As per the National Library Medicine 2024 report, surgical site infections are responsible for more than 2 million nosocomial infections in the US. To fight against surgical site infections, scientists have developed nanosilver-impregnated silk sutures. Nanosilver possesses antimicrobial properties, and its optical and structural characteristics make it an appealing candidate for biomedical applications. The increasing number of cases of surgical site infections is driving the need for sutures that have antimicrobial properties. In July 2022, Dolphin Sutures launched its antibacterial suture range containing triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent. Therefore, the increasing prevalence of surgical site infections is expected to create demand for antimicrobial surgical sutures and drive the growth of the antimicrobial surgical sutures market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Antimicrobial Surgical Suture Market: Strategic Insights

Antimicrobial Surgical Suture Market

• 
  CAGR (2023 - 2031)

  9.9%
• Market Size 2023
  US$ 0.35 Billion
• Market Size 2031
  US$ 0.75 Billion

Market Dynamics

GROWTH DRIVERS

• Increasing prevalence of surgical site infections are expected to create demand for antimicrobial surgical sutures and drive the growth of market.

FUTURE TRENDS

• Developments in smart antimicrobial surgical sutures are expected to bring new growth trends in the antimicrobial surgical sutures market growth in the coming years.

OPPORTUNITIES

• Continuous advancements in surgical sutures with product developments, innovations, product launches, product approvals, mergers, acquisitions, and partnerships are expected to present significant growth opportunities in the market.

Key Players

• TI Medical
• Healthium Medtech Limited
• Meril Life Sciences Pvt Ltd
• Unilene
• Johnson & Johnson
• Boz Medical
• Futura Surgicare Pvt Ltd (Dolphin Sutures)
• Cencora, Inc. (AmerisourceBergen Corporation)
• Advanced MedTech Solutions Pvt. Ltd.
• Internacional Farmacéutica SA.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture

Raw Materials

• Polyglactin 910 Antimicrobial Suture
• Poliglecaprone 25
• Polyglycolic Acid

Application

• Cardiovascular Surgery
• General Surgery
• Ophthalmic Surgery
• Gynecological Surgery
• Orthopedic Surgery
• Plastic Surgery
• Veterinary Surgery
• Dental Surgery
• Others

End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Antimicrobial Surgical Suture Market Drivers and Opportunities

Increasing Cases of Chronic Wounds and Surgeries Favor Antimicrobial Surgical Suture Market

According to the American College of Surgeons, ~1–2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.

Strategic Initiatives in Antimicrobial Surgical Suture to Create Opportunities for Antimicrobial Surgical Suture Market Growth

Antimicrobial surgical suturing holds tremendous potential for the success of surgical treatments of various ailments owing to their ability to prevent surgical site infections, which are one of the common causes of morbidity in postoperative setups. A few of the recent strategic initiatives by antimicrobial surgical suture market players are mentioned below.

• In September 2023, Genesis MedTech received approval from China's National Medical Products Administration (NMPA) for its absorbable sutures with antibacterial capabilities. The newly developed antibacterial sutures are coated with triclosan, which is a broad-spectrum antimicrobial agent with activity against Gram-positive and Gram-negative bacteria.

• In May 2023, Ethicon Plus Sutures became the first and only sutures with antibacterial protection recommended by NICE Medical Technologies guidance for use in the National Health Service (NHS) in the UK.

•  In July 2022, Dolphin Sutures launched its antibacterial sutures product lineup containing triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent.

• In May 2022, Ethicon, Inc., a Johnson & Johnson Company, filed 510(K) to receive premarket approval for PDS Plus Antibacterial (Polydioxanone) Sterile Synthetic Absorbable Surgical Suture.

Thus, continuous advancements in surgical sutures with product developments, innovations, product launches, product approvals, mergers, acquisitions, and partnerships are expected to present significant growth opportunities in the antimicrobial surgical suture market growth in the coming years.

Antimicrobial Surgical Suture Market Report Segmentation Analysis

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are product, application, source, and manufacturing.

• Based on type, the antimicrobial surgical suture market is classified into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture segment held a larger share of the market in 2023, and it is further anticipated to register a higher CAGR during the forecast period.
• Based on raw material, the antimicrobial surgical suture market is classified into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
• By application, the market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
• Based on end user, the antimicrobial surgical suture market is divided into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023. The pluripotent stem cells segment is anticipated to register the highest CAGR during the forecast period.

Antimicrobial Surgical Suture Market Share Analysis by Geography

The geographic scope of the antimicrobial surgical suture market report is mainly divided into five regions: North America, Asia Pacific, Europe, and the Middle East & Africa.

North America dominates the antimicrobial surgical suture market. The increasing surgical procedures and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, US$ 16.5 billion was spent on cosmetic procedures in the US in 2018. Medical facilities in the Mountain/Pacific region in the US are more famous for their expertise in cosmetic surgeries. More than 1.5 million surgical cosmetic operations and more than 5.5 million nonsurgical procedures were carried out in the US.

Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology's reports, ~800,000 deaths were noted in the US. Coronary heart disease is the primary cause of death, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries, in turn, fueling the need for antimicrobial surgical sutures in the US.

Antimicrobial Surgical Suture Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Antimicrobial Surgical Suture Market News and Recent Developments

The antimicrobial surgical suture market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

• Cencora, Inc. announced the completion of its name and stock ticker change from AmerisourceBergen Corporation, marking the latest stage of the company's evolution as a leader in global pharmaceutical services. The new name underscores Cencora's experience and vision regarding connecting manufacturers, providers, pharmacies, and patients and ensuring the consistent, reliable flow of treatments to those who need them at a time of growing complexity. (Cencora, Inc.; Press Release; May 2024)

Antimicrobial Surgical Suture Market Report Coverage and Deliverables

The "Antimicrobial Surgical Suture Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Antimicrobial surgical suture market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Antimicrobial surgical suture market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter's Five Forces and SWOT analysis
• Antimicrobial surgical suture market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the antimicrobial surgical suture market
• Detailed company profiles